Cambridge Innovation Capital

What is Cambridge Innovation Capital?

Cambridge Innovation Capital (CIC) is a venture capital firm founded in 2013, located in the UK and specializes in supporting knowledge-intensive businesses within the Cambridge ecosystem.

Leveraging a proprietary relationship with the University of Cambridge, they focus on investing in a broad range of industries including Software, IT and TMT, BioTech, FinTech and Financial Services, Hardware and Manufacturing, AI and Big Data, Blockchain and Cryptos, Material Science, Medical Devices and Hospital Services, DeepTech, Life Science, Mobile, and Oncology.

With an investment range from £600,000 to £6,000,000 and a sweet spot of around £3,300,000, CIC provides crucial financial backing and strategic guidance from the Angel and Seed stages to Series A and B, catering to early and later-stage companies. They aim to build leading businesses that emerge from Cambridge’s innovation-rich environment, supporting the most promising entrepreneurs in realising their vision of transformative and life-changing innovations. They pride themselves on their deep scientific knowledge and commercial expertise provided by the team and the technical and commercial advisors.

As of the moment, CIC reports having £0.5 billion in assets under management, with £0.25 billion invested across over 40 companies, and they have facilitated over £2.4 billion in co-investment capital. The firm is also committed to sustainability, and their investment activities are aligned with broader societal objectives, believing that prioritizing impact and ESG (Environmental, Social, and Governance) factors will enhance financial returns in the long term.

Regularly reporting on their ESG performance, CIC has been recognized for their transparency and commitment in this area.

What they say:

We are a leading UK VC fund that specialises in early stage deeptech and life science companies that have a deep technological innovation. Our investment team are all PhD-level each with many years experience in investing, technology, or both.

What we look for: We invest in all things deeptech: AI, robotics, quantum, software, fusion, cleantech. And in all things Life Sciences: medtech, therapeutics, genomics, drug discovery

How we help: We actively help founders with product-market fit, expanding a team, connecting them to our wider network, helping in future funding rounds, promoting their work, and much more.